Average Co-Inventor Count = 2.73
ph-index = 17
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Halozyme, Inc. (28 from 75 patents)
2. Genentech, Inc. (9 from 3,221 patents)
3. Celmed Oncology (usa), Inc. (6 from 8 patents)
4. Canji Inc. (5 from 42 patents)
5. Newbiotics, Inc. (5 from 5 patents)
6. Other (2 from 832,718 patents)
7. University of California (2 from 15,462 patents)
8. Northwestern University (1 from 2,117 patents)
9. Genzyme Corporation (1 from 787 patents)
10. The Salk Institute for Biological Studies (1 from 576 patents)
11. Genetech, Inc. (1 from 98 patents)
58 patents:
1. 12371685 - PH20 polypeptide variants with a modification at position 324 of the PH20 polypeptide and a method of making thereof
2. 12264345 - PH20 polypeptide variants, formulations and uses thereof
3. 12195773 - PH20 polypeptide variants, formulations and uses thereof
4. 12152262 - PH20 polypeptide variants, formulations and uses thereof
5. 12123035 - PH20 polypeptide variants, formulations and uses thereof
6. 12110520 - PH20 polypeptide variants, formulations and uses thereof
7. 12104184 - PH20 polypeptide variants, formulations and uses thereof
8. 12104185 - PH20 polypeptide variants, formulations and uses thereof
9. 12091692 - PH20 polypeptide variants, formulations and uses thereof
10. 12077791 - PH20 polypeptide variants with a modification at position 309 of the PH20 polypeptide and a method of making thereof
11. 12060590 - PH20 polypeptide variants, formulations and uses thereof
12. 12054758 - PH20 polypeptide variants, formulations and uses thereof
13. 12049652 - PH20 polypeptide variants, formulations and uses thereof
14. 12037618 - PH20 polypeptide variants, formulations and uses thereof
15. 12018298 - PH20 polypeptide variants, formulations and uses thereof